GlassScriptPhysician profile
Rebecca Sequeira
NPI 1013581248
$2,075.75
in general payments reported to CMS, 2019-2025
11 companies · $538 in 2025
The $538 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $583 · 2024: $955 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.48 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $829.58 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $227.84 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $224.65 | 2023-2024 | Airsupra, Breztri, Farxiga |
| Astellas Pharma US INC | $157.82 | 2025 | Veozah |
| Exact Sciences Corporation | $155.32 | 2023-2025 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $135.28 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.00 | 2023-2024 | Xifaxan |
| Amgen INC. | $100.97 | 2023-2024 | Repatha, Otezla |
| Pfizer INC. | $81.84 | 2023-2024 | |
| Dexcom, INC. | $35.53 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $23.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Sequeira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.